Maynard Um
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on Protara Therapeutics (TARA): "encouraged by Q4 operational update"
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Protera Therapeutics (TARA)
-
-
-
-
-
-
-
Protara Therapeutics, Inc. (TARA) Tops Q1 EPS by 18c
-
-
-
-
-
-
-
Protara Therapeutics, Inc. (TARA) Tops Q4 EPS by 11c
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Protera Therapeutics (TARA)
-
-
-
-
470,360 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


